Y. Gong

发表

Direct synthesis of unprotected 4-aryl phenylalanines via the Suzuki reaction under microwave irradiation.

Y. Gong, Wei He, 2002, Organic letters.

Effects of .alpha.- and .beta.-Silicon Atoms on the Free Energies of C-H Homolysis and Heterolysis

Y. Gong, M. Bausch, 1994 .

Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonists.

E. S. Kimball, P. Hornby, Y. Gong, 2008, Bioorganic & medicinal chemistry letters.

Aza-bicyclic amino acid carboxamides as α4β1/α4β7 integrin receptor antagonists

B. Maryanoff, C. Schneider, B. Damiano, 2005 .

Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.

D. Hlasta, B. Maryanoff, C. Schneider, 2006, Journal of medicinal chemistry.

Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa.

A. Spada, D. Colussi, Y. Gong, 2000, Bioorganic & medicinal chemistry letters.

Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand.

Robert Leadley, Guyan Liang, R. Bentley, 2003, Journal of medicinal chemistry.

Dimerization of β-tryptase inhibitors, does it work for both basic and neutral P1 groups?

I. Morize, Xin Chen, G. Liang, 2012, Bioorganic & medicinal chemistry letters.

Solid-phase parallel synthesis of azarene pyrrolidinones as factor Xa inhibitors.

J. Salvino, Y. M. Choi-Sledeski, Y. Gong, 2000, Bioorganic & medicinal chemistry letters.

Solid-phase parallel synthesis of 1,3,4-oxadiazole based peptidomimetic library as a potential modulator of protein-protein interactions

S. Yang, Aizhan Abdildinova, Y. Gong, 2017 .

Acylimine mediated N N bond cleavage of pyrazolidinediones and subsequent conversion to dihydropyrimidinediones and malonamides

Linhua Wang, Y. Gong, M. Bausch, 2001 .

A direct approach to the synthesis of 5-aryl-4-chloropyridazinone: From microwave assisted catalyst screen to room temperature regio- and chemoselective Suzuki arylation

Y. Gong, Wei He, 2004 .

Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity.

Daniel L Cheney, C. Dunwiddie, D. Cheney, 2002, Bioorganic & medicinal chemistry letters.

Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.

J. Li, M. Buntinx, P. Hornby, 2008, Bioorganic & Medicinal Chemistry Letters.

Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists.

J. Li, M. Buntinx, G. Van Lommen, 2008, Bioorganic & medicinal chemistry letters.